Texas child’s “measles pulmonary failure” sparks debate as media ignores vaccine risks and medical errors
Texas child’s “measles pulmonary failure” sparks debate as media ignores vaccine risks and medical errors
- An 8-year-old Texas girl died from “measles pulmonary failure,” prompting media to blame unvaccinated children while ignoring critical factors.
- Medical experts suggest the death may have resulted from improper treatment, not just measles, yet mainstream outlets refused to investigate.
- The MMR vaccine carries documented risks, including autism links and underreported injuries, but media only amplifies fear of infectious disease.
- Pharmaceutical giants Merck and GSK rake in billions from MMR sales, raising ethical concerns about profit-driven public health narratives.
- Natural immunity and alternative treatments show promise, but health officials push vaccines while sidelining safer options.
The hidden side of measles hysteria
When 8-year-old Daisy Hildebrand died in April from what Texas health officials labeled “measles pulmonary failure,” mainstream outlets like CNN and The Washington Post rushed to frame the tragedy as a cautionary tale about vaccine hesitancy. Missing from the headlines? The hospital’s refusal to disclose Daisy’s treatment protocol—or whether medical negligence played a role.
This pattern is nothing new. Every measles-related death becomes a media spectacle, while the thousands of annual MMR vaccine injuries—seizures, autism, and even fatalities—are buried by the same outlets. In February, another Texas child, a 6-year-old, died after measles led to pneumonia. But when Children’s Health Defense (CHD) obtained her medical records, renowned pulmonologist Dr. Pierre Kory concluded she died from medical errors, including delayed antibiotic treatment. The New York Times dismissed the claim as “unfounded,” omitting Kory’s credentials—a glaring omission in what should be objective journalism.
Vaccine risks vs. measles: A distorted narrative
While the mainstream media and health authorities emphasize the importance of vaccination, they often fail to disclose the serious risks associated with the MMR vaccine. The vaccine, which protects against measles, mumps, and rubella, has been linked to a range of adverse reactions, including febrile seizures, anaphylaxis, meningitis, encephalitis, thrombocytopenia, arthralgia, and vasculitis. According to the package insert for Merck’s MMRII, the vaccine has not been evaluated for carcinogenic or mutagenic potential or impairment of fertility.
Research by Physicians for Informed Consent (PIC) reveals that immunity from the MMR vaccine wanes over time, with about 60% of vaccinated children susceptible to sub-clinical measles infection and 33% of adults susceptible to clinical infection by age 24-26. This waning immunity suggests that the vaccine may not provide the long-term protection it is often touted to offer.
Moreover, a 2004 study found that boys vaccinated with their first MMR dose on time were 67% more likely to be diagnosed with autism compared to those vaccinated after their third birthday. Between 2000 and 2024, the Vaccine Adverse Event Reporting System (VAERS) recorded 144 deaths following MMR or MMRV vaccination, compared to nine measles-related deaths reported to the CDC during the same period. Given that VAERS is a passive reporting system, the actual number of vaccine-related injuries and deaths may be significantly higher.
Meanwhile, measles itself confers lifelong natural immunity—something the MMR can’t replicate. Yet public health officials never mention this. Instead, they push mass vaccination while ignoring troubling financial ties: Merck made 2.485 billion from MMR sales in 2024, while GSK pocketed over 411 million.
Why aren’t alternative treatments part of the conversation?
Clinics in Texas have quietly reported success treating measles complications with:
- Cod liver oil (packed with immune-boosting vitamins A and D)
- Budesonide (an anti-inflammatory steroid)
- Clarithromycin (a standard antibiotic)
But these options don’t generate pharmaceutical revenue—and thus, they’re excluded from mainstream coverage.
In 1962, The Saturday Evening Post exposed how Big Pharma colluded with regulators to downplay thalidomide’s birth defect risks—a scandal that shattered public trust. Today, history repeats itself as corporate media amplifies measles fear-mongering while sidelining MMR dangers, medical errors, and profit motives.
Will the truth about vaccine risks ever break through—or will the next tragic death simply be exploited to push more jabs?
Sources include:
